We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Planet Fitness
PLNT
$3.78B
| $38.6M | 0.09% |
516,912
-345,400
| -40% | -$23.3M |
|
227
Hubbell
HUBB
$27.2B
| $37.9M | 0.09% |
256,482
-24,854
| -9% | -$3.54M |
|
|
CMA
228
DELISTED
Comerica
CMA
| $37.9M | 0.09% |
527,707
-552,626
| -51% | -$37.9M |
|
229
Donaldson
DCI
$11.4B
| $37.6M | 0.09% |
652,057
-91,514
| -12% | -$4.98M |
|
230
WaFd
WAFD
$2.75B
| $37.4M | 0.09% |
1,020,532
+112,690
| +12% | +$4.14M |
|
231
Steven Madden
SHOO
$3.55B
| $37.1M | 0.09% |
863,367
+389,589
| +82% | +$15.7M |
|
232
iShares Russell 2000 ETF
IWM
$81.9B
| $37M | 0.09% |
223,182
+184,338
| +475% | +$29.1M |
|
233
Pinterest
PINS
$13.4B
| $36.7M | 0.09% |
1,969,658
+1,752,058
| +805% | +$37.8M |
|
234
Oshkosh
OSK
$9.59B
| $36.4M | 0.08% |
384,294
-149,046
| -28% | -$12.8M |
|
235
Prospect Capital
PSEC
$1.17B
| $36.3M | 0.08% |
5,642,687
+1,630,996
| +41% | +$10.6M |
|
236
ArcelorMittal
MT
$55.3B
| $36.3M | 0.08% |
2,069,964
+1,695,364
| +453% | +$27.5M |
|
237
KB Financial Group
KB
$43.5B
| $36.1M | 0.08% |
873,188
-104,413
| -11% | -$3.99M |
|
|
JHG
238
DELISTED
Janus Henderson
JHG
| $36M | 0.08% |
1,473,524
+467,282
| +46% | +$11.1M |
|
|
HBI
239
DELISTED
Hanesbrands
HBI
| $35.8M | 0.08% |
2,408,481
-294,926
| -11% | -$4.48M |
|
240
Fair Isaac
FICO
$22.5B
| $35.6M | 0.08% |
95,005
+85,264
| +875% | +$28.7M |
|
241
Thomson Reuters
TRI
$44.1B
| $35.5M | 0.08% |
470,132
-688,410
| -59% | -$50.1M |
|
242
Generac Holdings
GNRC
$12.5B
| $35.4M | 0.08% |
351,998
+106,992
| +44% | +$9.96M |
|
243
Floor & Decor
FND
$6.68B
| $35.3M | 0.08% |
694,977
+229,728
| +49% | +$10.8M |
|
244
TripAdvisor
TRIP
$1.26B
| $35.1M | 0.08% |
+1,156,125
| New | +$38.9M |
|
245
Chemours
CC
$2.37B
| $35M | 0.08% |
1,934,478
+1,091,118
| +129% | +$18.1M |
|
|
BIG
246
DELISTED
Big Lots, Inc.
BIG
| $34.9M | 0.08% |
1,216,888
-8,300
| -0.7% | -$192K |
|
247
Diageo
DEO
$53.6B
| $34.9M | 0.08% |
207,083
-842,531
| -80% | -$137M |
|
|
GRFS
248
Grifois
GRFS
$5.4B
| $34.2M | 0.08% |
1,469,176
+705,379
| +92% | +$15.4M |
|
249
Wheaton Precious Metals
WPM
$60.9B
| $34.1M | 0.08% |
+1,147,660
| New | +$31.4M |
|
|
PDCE
250
DELISTED
PDC Energy, Inc.
PDCE
| $34.1M | 0.08% |
1,303,823
+797,353
| +157% | +$19.1M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.